Mark J. SELBY

Person

San Francisco, CA, US

People

Patents Grantslast 30 patents

Information Patent Grant
Antibodies against TIM3 and uses thereof
- Patent number 12,129,297
- Issue date Oct 29, 2024
- Bristol-Myers Squibb Company
- Xiao Min Schebye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-CD27 antibodies and uses thereof
- Patent number 12,110,337
- Issue date Oct 8, 2024
- Bristol-Myers Squibb Company
- Li-Sheng Lu
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Modified B cells and methods of use thereof
- Patent number 12,037,604
- Issue date Jul 16, 2024
- Walking Fish Therapeutics, Inc.
- Kathleen Boyle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Grant
Modified B cells and methods of use thereof
- Patent number 11,913,023
- Issue date Feb 27, 2024
- Walking Fish Therapeutics, Inc.
- Kathleen Boyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against glucocorticoid-induced tumor necrosis factor rec...
- Patent number 11,802,162
- Issue date Oct 31, 2023
- Bristol-Myers Squibb Company
- Changyu Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against TIM3 and uses thereof
- Patent number 11,591,392
- Issue date Feb 28, 2023
- Bristol-Myers Squibb Company
- Xiao Min Schebye
- G01 - MEASURING TESTING
Information Patent Grant
Anti-ICOS agonist antibodies and uses thereof
- Patent number 11,529,399
- Issue date Dec 20, 2022
- Bristol-Myers Squibb Company
- John J. Engelhardt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...
- Patent number 11,530,267
- Issue date Dec 20, 2022
- E.R. Squibb & Sons, L.L.C.
- Kent B. Thudium
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...
- Patent number 11,512,130
- Issue date Nov 29, 2022
- E.R. Squibb & Sons, L.L.C.
- Kent B. Thudium
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-GITR antibodies for cancer diagnostics
- Patent number 11,408,889
- Issue date Aug 9, 2022
- Bristol-Myers Squibb Company
- Xi-Tao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies binding to ILT4
- Patent number 11,401,328
- Issue date Aug 2, 2022
- Five Prime Therapeutics, Inc.
- Xiao Min Schebye
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Combination of TIM-4 antagonist and PD-1 antagonist and methods of use
- Patent number 11,306,143
- Issue date Apr 19, 2022
- Bristol-Myers Squibb Company
- Sean E. Doyle
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to tr...
- Patent number 11,274,152
- Issue date Mar 15, 2022
- Bristol-Myers Squibb Company
- Alan J. Korman
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...
- Patent number 11,236,163
- Issue date Feb 1, 2022
- E.R. Squibb & Sons, L.L.C.
- Kent B. Thudium
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), an...
- Patent number 11,236,165
- Issue date Feb 1, 2022
- E.R. Squibb & Sons, L.L.C.
- Kent B. Thudium
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...
- Patent number 11,236,164
- Issue date Feb 1, 2022
- E.R. Squibb & Sons, L.L.C.
- Kent B. Thudium
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against glucocorticoid-induced tumor necrosis factor rec...
- Patent number 11,213,586
- Issue date Jan 4, 2022
- Bristol-Myers Squibb Company
- Changyu Wang
- G01 - MEASURING TESTING
Information Patent Grant
Anti-ICOS agonist antibodies and uses thereof
- Patent number 11,207,391
- Issue date Dec 28, 2021
- Bristol-Myers Squibb Company
- John J. Engelhardt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Antibodies against glucocorticoid-induced tumor necrosis factor rec...
- Patent number 11,084,881
- Issue date Aug 10, 2021
- Bristol-Myers Squibb Company
- Changyu Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), an...
- Patent number 11,001,630
- Issue date May 11, 2021
- E.R. Squibb & Sons, L.L.C.
- Kent B. Thudium
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...
- Patent number 10,988,536
- Issue date Apr 27, 2021
- E.R. Squibb & Sons, L.L.C.
- Kent B. Thudium
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...
- Patent number 10,988,535
- Issue date Apr 27, 2021
- E.R. Squibb & Sons, L.L.C.
- Kent B. Thudium
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-ICOS agonist antibodies and uses thereof
- Patent number 10,898,556
- Issue date Jan 26, 2021
- Bristol-Myers Squibb Company
- John J. Engelhardt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Anti-GITR antibodies for cancer diagnostics
- Patent number 10,690,674
- Issue date Jun 23, 2020
- Bristol-Myers Squibb Company
- Xi-Tao Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies comprising modified heavy constant regions
- Patent number 10,653,791
- Issue date May 19, 2020
- Bristol-Myers Squibb Company
- Nils Lonberg
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against TIM3 and uses thereof
- Patent number 10,533,052
- Issue date Jan 14, 2020
- Bristol-Myers Squibb Company
- Xiao Min Schebye
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against glucocorticoid-induced tumor necrosis factor rec...
- Patent number 10,501,550
- Issue date Dec 10, 2019
- Bristol-Myers Squibb Company
- Changyu Wang
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Anti-ICOS agonist antibodies and uses thereof
- Patent number 10,493,140
- Issue date Dec 3, 2019
- Bristol-Myers Squibb Company
- John J. Engelhardt
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Antibodies against glucocorticoid-induced tumor necrosis factor rec...
- Patent number 10,465,010
- Issue date Nov 5, 2019
- Bristol-Myers Squibb Company
- Changyu Wang
- C07 - ORGANIC CHEMISTRY
Information Patent Grant
Monoclonal antibodies to programmed death 1 (PD-1)
- Patent number 10,441,655
- Issue date Oct 15, 2019
- Ono Pharmaceutical Co., Ltd.
- Alan J. Korman
- C07 - ORGANIC CHEMISTRY

Patents Applicationslast 30 patents

Information Patent Application
ANTIBODIES AGAINST TIM3 AND USES THEREOF
- Publication number 20240209083
- Publication date Jun 27, 2024
- Bristol-Myers Squibb Company
- Xiao Min SCHEBYE
- G01 - MEASURING TESTING
Information Patent Application
METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3
- Publication number 20240174749
- Publication date May 30, 2024
- Bristol-Myers Squibb Company
- Xiao Min SCHEBYE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR REC...
- Publication number 20240158524
- Publication date May 16, 2024
- Bristol-Myers Squibb Company
- Changyu WANG
- G01 - MEASURING TESTING
Information Patent Application
Anti-LAG-3 Antibodies to Treat Hematological Malignancies
- Publication number 20240150459
- Publication date May 9, 2024
- Bristol-Myers Squibb Company
- Andres A. GUTIERREZ
- C07 - ORGANIC CHEMISTRY
Information Patent Application
ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS
- Publication number 20240141059
- Publication date May 2, 2024
- Bristol-Mayers Squibb Company
- Nils LONBERG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-ICOS AGONIST ANTIBODIES AND USES THEREOF
- Publication number 20240041995
- Publication date Feb 8, 2024
- Bristol-Myers Squibb Company
- John J. ENGELHARDT
- C07 - ORGANIC CHEMISTRY
Information Patent Application
MODIFIED B CELLS AND METHODS OF USE THEREOF
- Publication number 20240034995
- Publication date Feb 1, 2024
- Walking Fish Therapeutics
- Kathleen Boyle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
MODIFIED B CELLS AND METHODS OF USE THEREOF
- Publication number 20240002793
- Publication date Jan 4, 2024
- Walking Fish Therapeutics
- Kathleen Boyle
- C12 - BIOCHEMISTRY BEER SPIRITS WINE VINEGAR MICROBIOLOGY ENZYMOLOGY MUTATION...
Information Patent Application
ANTIBODIES AGAINST TIM3 AND USES THEREOF
- Publication number 20230382992
- Publication date Nov 30, 2023
- Bristol-Myers Squibb Company
- Xiao Min SCHEBYE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...
- Publication number 20230322919
- Publication date Oct 12, 2023
- E. R. SQUIBB & SONS, L.L.C.
- Kent B. THUDIUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS
- Publication number 20230287064
- Publication date Sep 14, 2023
- Bristol-Myers Squibb Company
- John J. ENGELHARDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Monoclonal Antibodies to Programmed Death 1 (PD-1)
- Publication number 20230272079
- Publication date Aug 31, 2023
- E. R. SQUIBB & SONS, L.L.C.
- Alan J. Korman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Antibodies Binding to ILT4
- Publication number 20230174647
- Publication date Jun 8, 2023
- Five Prime Therapeutics, Inc.
- Xiao Min Schebye
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CCR8 ANTIBODIES FOR TREATING CANCER
- Publication number 20230119066
- Publication date Apr 20, 2023
- Bristol-Myers Squibb Company
- Ruth Yin-Zong Lan
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A...
- Publication number 20230111786
- Publication date Apr 13, 2023
- Bristol-Myers Squibb Company
- Alan J. KORMAN
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)
- Publication number 20230061544
- Publication date Mar 2, 2023
- E. R. SQUIBB & SONS, L.L.C.
- Alan J. Korman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR REC...
- Publication number 20230050665
- Publication date Feb 16, 2023
- Bristol-Myers Squibb Company
- Changyu WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE
- Publication number 20220275091
- Publication date Sep 1, 2022
- Bristol-Myers Squibb Company
- Sean E. DOYLE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...
- Publication number 20220204612
- Publication date Jun 30, 2022
- E. R. SQUIBB & SONS, L.L.C.
- Kent B. THUDIUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...
- Publication number 20220195040
- Publication date Jun 23, 2022
- E. R. SQUIBB & SONS, L.L.C.
- Kent B. THUDIUM
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Tr...
- Publication number 20220185892
- Publication date Jun 16, 2022
- Bristol-Myers Squibb Company
- Alan J. Korman
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR REC...
- Publication number 20220175921
- Publication date Jun 9, 2022
- Bristol-Myers Squibb Company
- Changyu WANG
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTIBODIES AGAINST TIM3 AND USES THEREOF
- Publication number 20220089720
- Publication date Mar 24, 2022
- Bristol-Myers Squibb Company
- Xiao Min SCHEBYE
- G01 - MEASURING TESTING
Information Patent Application
MODIFIED B CELLS AND METHODS OF USE THEREOF
- Publication number 20220073876
- Publication date Mar 10, 2022
- Walking Fish Therapeutics
- Kathleen Boyle
- C07 - ORGANIC CHEMISTRY
Information Patent Application
METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3
- Publication number 20210363242
- Publication date Nov 25, 2021
- Bristol-Myers Squibb Company
- Xiao Min SCHEBYE
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A...
- Publication number 20210340250
- Publication date Nov 4, 2021
- Bristol-Myers Squibb Company
- Alan J. KORMAN
- C07 - ORGANIC CHEMISTRY
Information Patent Application
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...
- Publication number 20210261661
- Publication date Aug 26, 2021
- E. R. SQUIBB & SONS, L.L.C.
- Kent B. THUDIUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...
- Publication number 20210261660
- Publication date Aug 26, 2021
- E. R. SQUIBB & SONS, L.L.C.
- Kent B. THUDIUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...
- Publication number 20210261662
- Publication date Aug 26, 2021
- E. R. SQUIBB & SONS, L.L.C.
- Kent B. THUDIUM
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
ANTI-CD27 ANTIBODIES AND USES THEREOF
- Publication number 20210155703
- Publication date May 27, 2021
- Bristol-Myers Squibb Company
- Li-Sheng Lu
- C07 - ORGANIC CHEMISTRY

Mark J. SELBY

Person

Patents Grantslast 30 patents

Antibodies against TIM3 and uses thereof

Anti-CD27 antibodies and uses thereof

Modified B cells and methods of use thereof

Modified B cells and methods of use thereof

Antibodies against glucocorticoid-induced tumor necrosis factor rec...

Antibodies against TIM3 and uses thereof

Anti-ICOS agonist antibodies and uses thereof

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...

Anti-GITR antibodies for cancer diagnostics

Antibodies binding to ILT4

Combination of TIM-4 antagonist and PD-1 antagonist and methods of use

Combination of anti-LAG-3 antibodies and anti-PD-1 antibodies to tr...

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...

Human antibodies that bind Lymphocyte Activation Gene-3 (LAG-3), an...

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...

Antibodies against glucocorticoid-induced tumor necrosis factor rec...

Anti-ICOS agonist antibodies and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor rec...

Human antibodies that bind lymphocyte activation Gene-3 (LAG-3), an...

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...

Human antibodies that bind lymphocyte activation gene-3 (LAG-3), an...

Anti-ICOS agonist antibodies and uses thereof

Anti-GITR antibodies for cancer diagnostics

Antibodies comprising modified heavy constant regions

Antibodies against TIM3 and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor rec...

Anti-ICOS agonist antibodies and uses thereof

Antibodies against glucocorticoid-induced tumor necrosis factor rec...

Monoclonal antibodies to programmed death 1 (PD-1)

Patents Applicationslast 30 patents

ANTIBODIES AGAINST TIM3 AND USES THEREOF

METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3

ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR REC...

Anti-LAG-3 Antibodies to Treat Hematological Malignancies

ANTIBODIES COMPRISING MODIFIED HEAVY CONSTANT REGIONS

ANTI-ICOS AGONIST ANTIBODIES AND USES THEREOF

MODIFIED B CELLS AND METHODS OF USE THEREOF

MODIFIED B CELLS AND METHODS OF USE THEREOF

ANTIBODIES AGAINST TIM3 AND USES THEREOF

Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...

ENHANCING ANTI-CANCER ACTIVITY OF IMMUNOMODULATORY FC FUSION PROTEINS

Monoclonal Antibodies to Programmed Death 1 (PD-1)

Antibodies Binding to ILT4

ANTI-CCR8 ANTIBODIES FOR TREATING CANCER

COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A...

HUMAN MONOCLONAL ANTIBODIES TO PROGRAMMED DEATH LIGAND 1 (PD-L1)

ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR REC...

COMBINATION OF TIM-4 ANTAGONIST AND PD-1 ANTAGONIST AND METHODS OF USE

Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...

Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...

Combination of Anti-LAG-3 Antibodies and Anti-PD-1 Antibodies to Tr...

ANTIBODIES AGAINST GLUCOCORTICOID-INDUCED TUMOR NECROSIS FACTOR REC...

ANTIBODIES AGAINST TIM3 AND USES THEREOF

MODIFIED B CELLS AND METHODS OF USE THEREOF

METHODS OF TREATING CANCER WITH ANTIBODIES AGAINST TIM3

COMPOSITIONS COMPRISING A COMBINATION OF AN ANTI-LAG-3 ANTIBODY, A...

Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...

Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...

Human Antibodies that Bind Lymphocyte Activation Gene-3 (LAG-3), an...

ANTI-CD27 ANTIBODIES AND USES THEREOF